Anti-dumping duty has been imposed on as many as 90 items imported from China that include two pharmaceutical products, Parliament was informed on Friday.
"Further, 24 anti-dumping investigations are presently in progress against the alleged dumping of imports from China," Commerce and Industry Minister Piyush Goyal said in a written reply to the Rajya Sabha.
The Directorate General of Trade Remedies (DGTR), under the commerce ministry, conducts anti-dumping investigations on the basis of a duly substantiated application filed by domestic industry alleging dumping of goods into the country causing injury to the domestic industry.
The minister said that the basic intent of anti-dumping measures is to eliminate injury caused to the domestic industry by the unfair trade practice of dumping and to create a level-playing field for the domestic industry.
In a separate reply, he said the government has been consistently making efforts for achieving a more balanced trade with China.
India's trade with China decreased from USD 89.71 billion in 2017-18 to USD 87.07 billion in 2018-19.
During this period, India's imports from China declined from USD 76.38 billion in 2017-18 to USD 70.32 billion in 2018-19, and "our exports grew from USD 13.33 billion in 2017-18 to USD 16.75 billion in 2018-19," he said.
"As a result, India's trade deficit with China reduced from USD 63.05 billion to USD 53.57 billion in the said period," he added.
He , however, said that there are reports of some goods of Chinese origin coming into India from other countries like Singapore and Hong Kong, on which field formations have been appropriately sensitized.
Disclaimer: No Business Standard Journalist was involved in creation of this content
